In 2021, Ronald Rittenmeyer earned $18.67M in total compensation at Tenet Healthcare, including $1.50M salary, $6.75M bonus and $10.00M in stock. Most recently sold 250,000 shares in Mar 2022. Currently holds stock worth $101.90M. Led Tenet Healthcare as CEO for 4 years.
Compensation History
Annual executive compensation data for Ronald Rittenmeyer, including salary, bonuses, and stock awards.
Year
2021
Total Compensation
$18.67M
Salary
$1.50M
Bonus
$6.75M
Other
$416.15K
Salary
$1.50MBoard Justification
The compensation philosophy is designed to attract and retain top executive talent while aligning their interests with those of shareholders through performance-based incentives.
Bonus
$6.75MBoard Justification
The bonus is based on the company's performance metrics achieved at 200% of target under the Annual Incentive Plan for 2021, with an individual performance multiplier of 150%.
Other Compensation
$416.15KBoard Justification
Other compensation includes matching contributions under the 401(k) Retirement Savings Plan, contributions under the Executive Retirement Account, personal use of company aircraft, and personal use of a company car and driver for security reasons.
Restricted Stock
Board Justification
The stock awards granted on February 24, 2021, vest quarterly in equal installments ending on December 31, 2022.
Performance Metrics
The performance metrics for the CEO's compensation in 2021 included Adjusted EBITDA and Adjusted Free Cash Flow Less Cash Payments to Noncontrolling Interests.
Ronald Rittenmeyer
Ex-CEO of Tenet Healthcare
Education
Bachelor's degree in Business Administration
Field of Expertise
Business & Management - Business Management
Sector of Economy
Healthcare
Born
January 1, 1947 - 78 years ago
CEO of Tenet Healthcare for
4 years 0 months (Aug 2017 - Sep 2021)
Previous Experience
CEO of Millennium Health, CEO of Expert Global Solutions, various senior management positions at EDS
Holdings
Track Ronald Rittenmeyer's stock holdings and portfolio value over time.
Total Stock Sold
$59.53M
$59.53M
918,603 THC shares
What if they kept their stock?
If Ronald Rittenmeyer didn't sell their stock, today they would have:
Extra THC918,603 shares worth $194.87M.
This is 227.37% and $135.35M more than what they got when they sold the stock.
Insider Trading
Ronald Rittenmeyer's recent stock transactions, purchases, and sales filed with the SEC.
$22.59M
THC at $90.34/share
Mar 2, 2022
Sale
$451.51K
THC at $77.86/share
Dec 16, 2021
Sale
$462.84K
THC at $76.00/share
Dec 10, 2021
Sale
$5.87M
THC at $76.02/share
Dec 7, 2021
Sale
$12.05K
THC at $79.25/share
Nov 24, 2021
Sale
$1.74M
THC at $79.28/share
Nov 23, 2021
Sale
$2.34M
THC at $79.01/share
Nov 19, 2021
Sale
$3.94M
THC at $79.00/share
Nov 18, 2021
Sale
Rivals
Compare Ronald Rittenmeyer with competitor CEOs and industry peers.
Samuel N. Hazen
CEO of HCA Healthcare
2023 Compensation
Stock
$24.94M
Salary
$1.51M
Bonus
$5.03M
Other
$577.42K
Total Holdings
$24.53M
Christopher H. Hunter
CEO of Acadia Healthcare
2023 Compensation
Stock
$0.00
Salary
$1.00M
Bonus
$1.65M
Other
$962.00
Total Holdings
$8.72M
Eric Evans
CEO of Surgery Partners, Inc.
2023 Compensation
Stock
$0.00
Salary
$1.05M
Bonus
$1.00M
Other
$7.60K
Total Holdings
$31.39M
Marc D. Miller
CEO of Universal Health Services
2024 Compensation
Stock
$0.00
Salary
$0.00
Bonus
$0.00
Other
$29.79K
Total Holdings
$2.92M
David S. Chernow
CEO of Select Medical Holdings
2023 Compensation
Stock
$5.88M
Salary
$995.00K
Bonus
$1.89M
Other
$340.77K
Total Holdings
$34.96M